Related Articles
Oxidative stress parameters in paediatric non-alcoholic fatty liver disease
Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline
Construction and expression of recombinant uricase‑expressing genetically engineered bacteria and its application in rat model of hyperuricemia
Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus
Markers of activated inflammatory cells are associated with disease severity and intestinal microbiota in adults with non‑alcoholic fatty liver disease